Matches in SemOpenAlex for { <https://semopenalex.org/work/W2115128424> ?p ?o ?g. }
- W2115128424 endingPage "619" @default.
- W2115128424 startingPage "613" @default.
- W2115128424 abstract "This phase II trial investigated rituximab and cladribine in chronic lymphocytic leukemia. Four induction cycles, comprising cladribine (0.1 mg/kg/day days 1-5, cycles 1-4) and rituximab (375 mg/m(2) day 1, cycles 2-4), were given every 28 days. Stem cell mobilization (rituximab 375 mg/m(2) days 1 and 8; cyclophosphamide 4 g/m(2) day 2; and granulocyte colony-stimulating factor 10 microg/kg/day, from day 4) was performed in responders. Of 42 patients, nine achieved complete remission (CR), 15 very good partial remission, and two nodular partial remission (overall response rate 62%). Stem cell mobilization and harvesting (> or = 2 x 10(6) stem cells/kg body weight) were successful in 12 of 20 patients. Rituximab infusion-related adverse events were moderate. The main grade 3/4 adverse events during induction were neutropenia and lymphocytopenia. Rituximab plus cladribine was effective; however, the CR rate was modest and stem cell harvest was impaired in a large number of responding patients." @default.
- W2115128424 created "2016-06-24" @default.
- W2115128424 creator A5011625621 @default.
- W2115128424 creator A5012351880 @default.
- W2115128424 creator A5023337106 @default.
- W2115128424 creator A5041892684 @default.
- W2115128424 creator A5045933366 @default.
- W2115128424 creator A5046258011 @default.
- W2115128424 creator A5052963549 @default.
- W2115128424 creator A5060931844 @default.
- W2115128424 creator A5065318486 @default.
- W2115128424 creator A5075265048 @default.
- W2115128424 creator A5080851756 @default.
- W2115128424 creator A5085702050 @default.
- W2115128424 date "2010-04-01" @default.
- W2115128424 modified "2023-09-27" @default.
- W2115128424 title "Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02)" @default.
- W2115128424 cites W1777794242 @default.
- W2115128424 cites W1972073735 @default.
- W2115128424 cites W1986122954 @default.
- W2115128424 cites W1988217711 @default.
- W2115128424 cites W1993827226 @default.
- W2115128424 cites W1995149380 @default.
- W2115128424 cites W2021075058 @default.
- W2115128424 cites W2023522606 @default.
- W2115128424 cites W2024386952 @default.
- W2115128424 cites W2030682618 @default.
- W2115128424 cites W2033687056 @default.
- W2115128424 cites W2041925366 @default.
- W2115128424 cites W2044518340 @default.
- W2115128424 cites W2070193300 @default.
- W2115128424 cites W2071573786 @default.
- W2115128424 cites W2099489547 @default.
- W2115128424 cites W2100456851 @default.
- W2115128424 cites W2107567250 @default.
- W2115128424 cites W2116249739 @default.
- W2115128424 cites W2116262245 @default.
- W2115128424 cites W2117648265 @default.
- W2115128424 cites W2125134816 @default.
- W2115128424 cites W2129041705 @default.
- W2115128424 cites W2142099365 @default.
- W2115128424 cites W2150677488 @default.
- W2115128424 cites W2152229600 @default.
- W2115128424 cites W2157514847 @default.
- W2115128424 cites W2157720475 @default.
- W2115128424 cites W2161926682 @default.
- W2115128424 cites W2184110849 @default.
- W2115128424 cites W2275948481 @default.
- W2115128424 cites W2316778105 @default.
- W2115128424 cites W2318261848 @default.
- W2115128424 cites W2323897083 @default.
- W2115128424 cites W2326175431 @default.
- W2115128424 cites W4376595664 @default.
- W2115128424 doi "https://doi.org/10.3109/10428191003624231" @default.
- W2115128424 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20218808" @default.
- W2115128424 hasPublicationYear "2010" @default.
- W2115128424 type Work @default.
- W2115128424 sameAs 2115128424 @default.
- W2115128424 citedByCount "8" @default.
- W2115128424 countsByYear W21151284242012 @default.
- W2115128424 countsByYear W21151284242014 @default.
- W2115128424 countsByYear W21151284242018 @default.
- W2115128424 crossrefType "journal-article" @default.
- W2115128424 hasAuthorship W2115128424A5011625621 @default.
- W2115128424 hasAuthorship W2115128424A5012351880 @default.
- W2115128424 hasAuthorship W2115128424A5023337106 @default.
- W2115128424 hasAuthorship W2115128424A5041892684 @default.
- W2115128424 hasAuthorship W2115128424A5045933366 @default.
- W2115128424 hasAuthorship W2115128424A5046258011 @default.
- W2115128424 hasAuthorship W2115128424A5052963549 @default.
- W2115128424 hasAuthorship W2115128424A5060931844 @default.
- W2115128424 hasAuthorship W2115128424A5065318486 @default.
- W2115128424 hasAuthorship W2115128424A5075265048 @default.
- W2115128424 hasAuthorship W2115128424A5080851756 @default.
- W2115128424 hasAuthorship W2115128424A5085702050 @default.
- W2115128424 hasConcept C126322002 @default.
- W2115128424 hasConcept C141071460 @default.
- W2115128424 hasConcept C143998085 @default.
- W2115128424 hasConcept C197934379 @default.
- W2115128424 hasConcept C203014093 @default.
- W2115128424 hasConcept C2776694085 @default.
- W2115128424 hasConcept C2776755627 @default.
- W2115128424 hasConcept C2777063308 @default.
- W2115128424 hasConcept C2777767877 @default.
- W2115128424 hasConcept C2777938653 @default.
- W2115128424 hasConcept C2778461978 @default.
- W2115128424 hasConcept C2779200787 @default.
- W2115128424 hasConcept C2779338263 @default.
- W2115128424 hasConcept C2780653079 @default.
- W2115128424 hasConcept C31760486 @default.
- W2115128424 hasConcept C71924100 @default.
- W2115128424 hasConcept C90924648 @default.
- W2115128424 hasConceptScore W2115128424C126322002 @default.
- W2115128424 hasConceptScore W2115128424C141071460 @default.
- W2115128424 hasConceptScore W2115128424C143998085 @default.
- W2115128424 hasConceptScore W2115128424C197934379 @default.
- W2115128424 hasConceptScore W2115128424C203014093 @default.
- W2115128424 hasConceptScore W2115128424C2776694085 @default.